AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2011
Apr 15, 2011
34519_dirs_2011-04-15_c2798008-14a7-45c9-9c04-855df0050685.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2010-01-04
Reporting Person: Kunde Bobbi Jo (Director of Sales & Marketing)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $3.65 | 2020-01-03 | Common Stock (5000) | Direct |
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23